Mkaouar Héla, Akermi Nizar, Kriaa Aicha, Abraham Anne-Laure, Jablaoui Amin, Soussou Souha, Mokdad-Gargouri Raja, Maguin Emmanuelle, Rhimi Moez
INRA, UMR1319 MICALIS, Jouy-en-Josas, France, AgroParisTech, UMR MICALIS, Jouy-en-Josas, France.
MaIAGE, INRA, Université Paris-Saclay, Jouy-en-Josas, France.
PeerJ. 2019 Aug 30;7:e7224. doi: 10.7717/peerj.7224. eCollection 2019.
Serine Protease Inhibitors (Serpins) control tightly regulated physiological processes and their dysfunction is associated to various diseases. Thus, increasing interest is given to these proteins as new therapeutic targets. Several studies provided functional and structural data about human serpins. By comparison, only little knowledge regarding bacterial serpins exists. Through the emergence of metagenomic studies, many bacterial serpins were identified from numerous ecological niches including the human gut microbiota. The origin, distribution and function of these proteins remain to be established. In this report, we shed light on the key role of human and bacterial serpins in health and disease. Moreover, we analyze their function, phylogeny and ecological distribution. This review highlights the potential use of bacterial serpins to set out new therapeutic approaches.
丝氨酸蛋白酶抑制剂(Serpins)控制着严格调控的生理过程,其功能障碍与多种疾病相关。因此,这些蛋白质作为新的治疗靶点受到越来越多的关注。多项研究提供了关于人类丝氨酸蛋白酶抑制剂的功能和结构数据。相比之下,关于细菌丝氨酸蛋白酶抑制剂的知识却很少。随着宏基因组学研究的出现,从包括人类肠道微生物群在内的众多生态位中鉴定出了许多细菌丝氨酸蛋白酶抑制剂。这些蛋白质的起源、分布和功能仍有待确定。在本报告中,我们阐明了人类和细菌丝氨酸蛋白酶抑制剂在健康和疾病中的关键作用。此外,我们分析了它们的功能、系统发育和生态分布。这篇综述强调了细菌丝氨酸蛋白酶抑制剂在开发新治疗方法方面的潜在用途。